Description
PelitinibisanirreversIBLeEFGRinhibitorthatexhibitsanticancerchemotherapeuticbenefitinthetreatmentofnon-smallcelllungcancer(NSCLC)andothersolidtumorcancers.Invitro,pelitinibinhibitsNF-κB,inhibitingtranscriptionofTERTandtelomeraseactivity.PelitinibalsodecreasesphosphorylationofAktandERKandinducescellcyclearrestinvitro.
References
AravindanN,AravindanS,HermanTS,etal.EGFRtyrosinekinaseinhibitorpelitinibregulatesrADIation-inducedp65-dependenttelomeraseactivationinsquamouscellcarcinoma.RadiatRes.2013Mar;179(3):304-12.PMID:23379415.
KimH,LimHY.NovelEGFR-TKinhibitorEKB-569inhibitshepatocellularcarcinomacellproliferationbyAKTandMAPKpathways.JKoreanMedSci.2011Dec;26(12):1563-8.PMID:22147992.
YoshimuraN,KudohS,KimuraT,etal.EKB-569,anewirreversibleepidermalgrowthfactorreceptortyrosinekinaseinhibitor,withclinicalactivityinpatientswithnon-smallcelllungcancerwithacquiredresistancetogefitinib.LungCancer.2006Mar;51(3):363-8.PMID:16364494.